[Cytostatic treatment of lymphogranulomatosis. Experiences with ibenzmethyzine, cyclophosphamide and vinblastine sulfate].
D000505:Alopecia / Q000139:chemically induced; D000553:Ambulatory Care; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage* / Q000009:adverse effects; D007275:Injections, Intravenous; D007970:Leukopenia / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D013431:Sulfates / Q000008:administration & dosage; D013921:Thrombocytopenia / Q000139:chemically induced; D013924:Thrombophlebitis / Q000139:chemically induced; D014747:Vinblastine / Q000008:administration & dosage* / Q000009:adverse effects; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents; D006834:Hydrazines; D013431:Sulfates; D014747:Vinblastine; D003520:Cyclophosphamide
Zytostatische Behandlung der Lymphogranulomatose. Erfahrungen mit ibenzmethyzin, Cyclophosphamid und Vinblastinsulfat.